Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients

被引:0
作者
Rocha, Ana T. [1 ]
Paiva, Edison F. [2 ]
Lichtenstein, Arnaldo [2 ]
Milani, Rodolfo, Jr. [2 ]
Cavalheiro-Filho, Cyrillo [3 ]
Maffei, Francisco H. [4 ]
机构
[1] Univ Fed Bahia, Salvador, BA, Brazil
[2] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Coracao Hosp Clin, Fac Med, Sao Paulo, Brazil
[4] Fac Med Botucatu, Botucatu, SP, Brazil
关键词
embolism and thrombosis; risk factors; prevention and control; heparin; riskassessment; guideline;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The risk for venous thromboembolism (VTE) in medical patients is high, but risk assessment is rarely performed because there is not yet a good method to identify candidates for prophylaxis. Purpose: To perform a systematic review about VTE risk factors (RFs) in hospitalized medical patients and generate recommendations (RECs) for prophylaxis that can be implemented into practice. Data sources: A multidisciplinary group of experts from 12 Brazilian Medical Societies searched MEDLINE, Cochrane, and LILACS. Study selection: Two experts independently classifi ed the evidence for each RF by its scientifi c quality in a standardized manner. A risk-assessment algorithm was created based on the results of the review. Data synthesis: Several VTE RFs have enough evidence to support RECs for prophylaxis in hospitalized medical patients (eg, increasing age, heart failure, and stroke). Other factors are considered adjuncts of risk (eg, varices, obesity, and infections). According to the algorithm, hospitalized medical patients >= 40 years-old with decreased mobility, and >= 1 RFs should receive chemoprophylaxis with heparin, provided they don't have contraindications. High prophylactic doses of unfractionated heparin or low-molecular-weight-heparin must be administered and maintained for 6-14 days. Conclusions: A multidisciplinary group generated evidence-based RECs and an easy-to-use algorithm to facilitate VTE prophylaxis in medical patients.
引用
收藏
页码:533 / 553
页数:21
相关论文
共 225 条
  • [71] GROSHONG CATHETER-ASSOCIATED SUBCLAVIAN VENOUS THROMBOSIS
    GOULD, JR
    CARLOSS, HW
    SKINNER, WL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1993, 95 (04) : 419 - 423
  • [72] Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study
    Grady, D
    Wenger, NK
    Herrington, D
    Khan, S
    Furberg, C
    Hunninghake, D
    Vittinghoff, E
    Hulley, S
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) : 689 - +
  • [73] Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke
    Gregory, PC
    Kuhlemeier, KV
    [J]. AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2003, 82 (05) : 364 - 369
  • [74] Hormone replacement therapy and risk of venous thromboembolism: Population based case-control study
    Gutthann, SP
    Rodriguez, LAG
    Castellsague, J
    Oliart, AD
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7083): : 796 - 800
  • [75] Smoking and abdominal obesity -: Risk factors for venous thromboembolism among middle-aged Men:: "The study of men born in 1913"
    Hansson, PO
    Ericksson, H
    Welin, L
    Svärdsudd, K
    Wilhelmsen, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (16) : 1886 - 1890
  • [76] Harenberg J, 1996, HAEMOSTASIS, V26, P127
  • [77] Harenberg J, 1999, BLOOD, V94, p399A
  • [78] Heaton DC, 2002, INTERN MED J, V32, P84, DOI 10.1046/j.1445-5994.2002.d01-28.x
  • [79] Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study
    Heit, JA
    Silverstein, MD
    Mohr, DN
    Petterson, TM
    O'Fallon, WM
    Melton, LJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (06) : 809 - 815
  • [80] Relative impact of risk factors for deep vein thrombosis and pulmonary embolism - A population-based study
    Heit, JA
    O'Fallon, WM
    Petterson, TM
    Lohse, CM
    Silverstein, MD
    Mohr, DN
    Melton, LJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (11) : 1245 - 1248